PHARMAACE H-1B Visa Sponsorship & Salary Data

The median H-1B salary at PHARMAACE is $105,629, based on 104 certified filings from FY 2020 to FY 2026. This is 12% lower than the national H-1B median salary of $120,000. Compensation at PHARMAACE reflects their market positioning, with entry-level roles starting around $86,278 and senior positions reaching $157,761 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at PHARMAACE range from $74,750 at the 10th percentile to $157,761 at the 90th percentile, showing a $83,011 spread across experience levels and roles. The 25th percentile is $86,278 and the 75th percentile is $139,535.

Yes, PHARMAACE actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), PHARMAACE filed 2 H-1B labor condition applications with 2 certified and 0 denied, at a median salary of $140,000. Across FY 2020–2026, they have filed 105 total H-1B applications with 104 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. PHARMAACE sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), PHARMAACE filed 2 H-1B applications, with 2 certified and 0 denied. Over 7 years of data, PHARMAACE has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

PHARMAACE's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 105 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating PHARMAACE as a potential H-1B sponsor.

This is an excellent approval rate, indicating PHARMAACE has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

PHARMAACE sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 104 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles PHARMAACE most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at PHARMAACE:

The most frequently sponsored role is Analyst/Consultant (Pharmaceutical Analytics) with 47 filings at a median salary of $86,278. This is followed by Engagement Manager (Pharmaceutical Analytics) (17 filings) and Project Manager.

PHARMAACE's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where PHARMAACE sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top PHARMAACE H-1B locations:

The largest H-1B hub for PHARMAACE is Princeton, NJ with 102 filings at a median salary of $105,629. The highest-paying location is 2Nd Floor, NJ at $154,077 median. Salaries range from $80,500 to $154,077 across office locations.

PHARMAACE's median H-1B salary has increased by +40% from FY 2020 ($100,000) to FY 2026 ($140,000). Tracking salary trends over time reveals how PHARMAACE adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at PHARMAACE.

Year-by-year breakdown:

• FY 2022: $110,000 (16 certified)
• FY 2023: $100,000 (16 certified)
• FY 2024: $108,000 (18 certified)
• FY 2025: $146,000 (17 certified)
• FY 2026: $140,000 (2 certified)

This 40% growth reflects strong compensation adjustments at PHARMAACE, keeping pace with market demands for H-1B talent.

PHARMAACE primarily files H-1B applications at Wage Level II, accounting for 58% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making PHARMAACE's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 85% of positions at Level II or higher, PHARMAACE typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

PHARMAACE's median H-1B salary of $105,629 is 12% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating PHARMAACE's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare PHARMAACE's offerings with similar companies in your field for a more accurate assessment.

PHARMAACE's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. PHARMAACE files 15% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 104 certified filings, PHARMAACE invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.